NCT04557540

Brief Summary

This trial compares the effect of intermittent fasting versus continuous caloric reduction for the reduction of body weight in Black adults of faith. Intermittent fasting and continuous caloric reduction interventions may help Black adults of faith lose weight, improve their health, and help reduce cancer risk.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 9, 2020

Completed
12 days until next milestone

First Posted

Study publicly available on registry

September 21, 2020

Completed
1 year until next milestone

Study Start

First participant enrolled

September 25, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 7, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 7, 2022

Completed
Last Updated

January 16, 2024

Status Verified

January 1, 2024

Enrollment Period

1.2 years

First QC Date

September 9, 2020

Last Update Submit

January 12, 2024

Conditions

Outcome Measures

Primary Outcomes (7)

  • Change in body weight

    Up to 6 months

  • Changes in body composition

    up to 6 months

  • Change in height

    up to 6 months

  • Change in heart rate

    Up to 6 months

  • Change in blood pressure

    AT 6 months

  • Change in waist circumference

    Up to t 6 months

  • Change in hip circumference

    Up to 6 months

Secondary Outcomes (5)

  • Dietary intake

    Up to 6 months

  • Obesity-related biomarker analysis

    Up to 6 months

  • glucose metabolism

    UP to 6 months

  • changes in Adipokine levels

    Up to 6 months

  • C-Peptide level

    Up to 6 months

Study Arms (2)

Arm I (Fasting WORD)

EXPERIMENTAL

Participants receive the Fasting WORD intermittent fasting weight loss intervention consisting of 16 small-group lessons over 1.5 hours each QW for 2 months and then Q2W for 4 months.

Other: Quality-of-Life AssessmentOther: Questionnaire AdministrationOther: Short-Term Fasting

Arm II (The WORD)

EXPERIMENTAL

Participants receive The WORD CER weight loss intervention consisting of 16 small-group lessons over 1.5 hours each QW for 2 months and then Q2W for 4 months.

Behavioral: Lifestyle TherapyOther: Quality-of-Life AssessmentOther: Questionnaire Administration

Interventions

Receive The WORD lifestyle CER weight loss intervention

Arm II (The WORD)

Ancillary studies

Also known as: Quality of Life Assessment
Arm I (Fasting WORD)Arm II (The WORD)

Ancillary studies

Arm I (Fasting WORD)Arm II (The WORD)

Receive Fasting WORD intermittent fasting weight loss intervention

Also known as: Intermittent Fasting, Short-term Intermittent Fasting
Arm I (Fasting WORD)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • African American/Black
  • Body mass index (BMI) \> 25 kg/m\^2
  • Associated with a participating church through membership or participation in a church activity
  • Cleared by a Primary Care Provider (PCP-Doctor) to be a part of the study
  • Not currently on weight loss medications
  • Not pregnant or lactating
  • Has not lost at least 10% of their body weight in the last 6 months
  • Has not had bariatric surgery in the last 10 years
  • Able to walk unassisted and continuously for 10 minutes

You may not qualify if:

  • Adults unable to consent
  • Adults unable to complete study measures in English
  • Individuals who are not yet adults (infants, children, teenagers)
  • Individuals who are pregnant or lactating
  • Adults who have had a myocardial infarction (heart attack) or stroke without medical clearance from their primary care physician to participate in the study
  • Adults who currently have type 1 or type 2 diabetes without medical clearance from their primary care physician to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Roswell Park Cancer Institute

Buffalo, New York, 14263, United States

Location

Study Officials

  • Karen Yeary

    Roswell Park Cancer Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 9, 2020

First Posted

September 21, 2020

Study Start

September 25, 2021

Primary Completion

December 7, 2022

Study Completion

December 7, 2022

Last Updated

January 16, 2024

Record last verified: 2024-01

Locations